Date: 2017-02-28
Type of information: Restructuring
Compound:
Company: Veloxis Pharmaceuticals (Denmark)
Therapeutic area:
Type agreement: restructuring
Action mechanism:
Disease:
Details: • On February 28, 2017, Veloxis Pharmaceuticals announced that its US subsidiary, Veloxis Pharmaceuticals Inc., has decided to close its office in Edison, New Jersey effective Tuesday, 28 February, 2017. All of the company's operations will now be based out of its Cary, North Carolina office.
Financial terms:
Latest news:
